As a Free StocksGuide user, you can view scores for all 7,002 stocks worldwide.
10 Analysts have issued a CapsoVision forecast:
10 Analysts have issued a CapsoVision forecast:
Jun '25 |
+/-
%
|
||
Revenue | 18 18 |
-
|
|
Gross Profit | 9.68 9.68 |
-
|
|
EBITDA | -29 -29 |
-
|
|
EBIT (Operating Income) EBIT | -30 -30 |
-
|
|
Net Profit | -30 -30 |
-
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
CapsoVision Inc is a US-based company operating in industry. The company is headquartered in Saratoga California, California. The company went IPO on 2025-07-02. CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Head office | United States |
Website | www.capsovision.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.